Skip to main content
. Author manuscript; available in PMC: 2023 May 18.
Published in final edited form as: Neuron. 2022 Mar 15;110(10):1671–1688.e6. doi: 10.1016/j.neuron.2022.02.011

Figure 1. CRISPR/Cas9 editing of Stmn2.

Figure 1.

(A) Diagram of breeding strategy to generate Stmn2 F0, Rosa26 gRNA, and Stmn2 F2 mice. (B) Schematic representation of the STMN2 locus in which gRNAs were targeted to exons 2 and 4 to create a predicted 13 Kb deletion. Primers were designed to flank the region of the deletion region to confirm the presence or absence of mutations. (C) PCR genotyping of F2 Stmn2 mice exhibiting WT (+/+), heterozygous (+/−), and homozygous (−/−) mutations. (D) F2 Stmn2 brain mRNA levels flanking Exons 1 to 3 (left) and Exons 4 to 5 (right). (E) Spinal cord and brain Stmn2 protein levels from Western blots including the housekeeping protein GAPDH. **** p < 0.0001. In all figures: results are shown as a mean with error bars calculated as standard deviation. Detailed information (average, SD, n and detailed statistics) is shown in STAR Methods.